PANBELA THERAPEUTICS INC (PBLA)       0.0964  +0 (+4.1%)

0.0964  +0 (+4.1%)

US69833W1071 - Common Stock - Premarket: 0.0991 +0 (+2.8%)

News Image
8 days ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Good morning! We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about!

News Image
9 days ago - Chartmill

These stocks are moving in today's after hours session

The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today.

News Image
10 days ago - Chartmill

Tuesday's after hours session: top gainers and losers

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

News Image
11 days ago - Panbela Therapeutics, Inc.

Panbela Announces First Patients Enrolled in Europe for ASPIRE Trial Studying Ivospemin (SBP-101) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

MINNEAPOLIS, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics...

News Image
11 days ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Welcome back, trader! It's time to check out the biggest pre-market stock movers that traders will want to know about on Monday!

News Image
a month ago - Panbela Therapeutics, Inc.

Panbela Provides Business Update and Reports Q3 2022 Financial Results

MINNEAPOLIS, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA) , a clinical stage company developing disruptive therapeutics...

News Image
a month ago - Panbela Therapeutics, Inc.

Panbela Schedules Conference Call on, November 10, 2022, to Report 2022 Third Quarter Financial Results

MINNEAPOLIS, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for...

News Image
a month ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Pre-market stock movers continue to be a major topic as we dive into the latest news investors need to know about on Friday!

News Image
2 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Get ready for one more day of trading this week as we break down the biggest pre-market stock movers for Friday morning!

News Image
2 months ago - Panbela Therapeutics, Inc.

Panbela Announces Pricing of Approximately $6 Million Public Offering

MINNEAPOLIS, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), (“Panbela” or the “Company”), a clinical stage company...

News Image
2 months ago - Panbela Therapeutics, Inc.

Panbela Receives Approvals to Open Trial Sites in Spain, France and Italy for ASPIRE Trial Studying Ivospemin (SBP-101) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

MINNEAPOLIS, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics...

News Image
3 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're breaking down the biggest pre-market stock movers for Friday morning alongside the news that traders need to know about!

News Image
3 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning and the news behind them!

News Image
4 months ago - Panbela Therapeutics, Inc.

Panbela Provides Business Update and Reports Q2 2022 Financial Results

MINNEAPOLIS, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for...

News Image
4 months ago - Panbela Therapeutics, Inc.

Panbela Expands Aspire Trial to Australia, Studying SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

MINNEAPOLIS, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for...

News Image
4 months ago - Panbela Therapeutics, Inc.

Panbela Schedules Conference Call on, August 15, 2022, to Report 2022 Second Quarter Financial Results

MINNEAPOLIS, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for...